"Let me note this just in case" — as these words accumulate, the correction request grows long, the other's defence grows deep, and even the findings that truly mattered become buried. This volume reads this phenomenon in the field of regulatory review through the concept of the zero-risk illusion. Bringing risk to zero is, in principle, impossible — yet we frequently try to approach zero, and in doing so generate another risk: over-finding. Sunstein, Slovic, Beck, Aristotle, the Buddha, and Taleb — six traditions on the practice of an adult relationship with risk.

01"Zero Risk" — a Contradiction in Terms

The expression "bring risk to zero" is commonly used, but on reflection it contains a contradiction. Risk is "the product of the probability and the impact of an undesirable event." To make both probability and impact strictly zero is impossible in principle in the real world. Yet we frequently move with zero risk as the goal. Why?

One reason is that human cognition of risk is not probabilistic but emotional. Even at small probability, an event that is easy to imagine and dreadful is overrated; even at large probability, an event that is everyday and familiar is underrated. When "findings just in case" multiply in the field of regulatory review, we are often pulled by the worst-case scenario that is easy to imagine. The first two of this volume — Sunstein and Slovic — illuminated this scientifically.

02Sunstein, "Laws of Fear" — Risk-Perception Bias and Over-Regulation

The American legal scholar Cass Sunstein (1954–), in Laws of Fear (2005), thoroughly analysed the cognitive biases around risk in individuals and society. His central proposition:

"The instinct to aim at zero risk (zero-risk bias) is deeply embedded in human cognition. But the pursuit of zero risk frequently generates other risks. The opportunity cost of risk reduction, the cost of over-regulation, secondary harms — these are overlooked." — paraphrase of Cass Sunstein, Laws of Fear (2005)

What Sunstein shows is the paradox that "lowering risk," which is in itself desirable, depending on context can on the whole increase risk. In approaching one risk toward zero, other risks (time, cost, trust, opportunity loss) grow. In the pharmaceutical field, multiplying "findings just in case" on one material generates other risks — important findings are buried, trust with the requester is damaged, the organisation's processing capacity is squeezed. Risk cannot be seen as a single number but only as the equilibrium relation among multiple risks.

03Slovic, "Dread and the Unknown" — Risks That Feel Frightening Are Overrated

The American psychologist Paul Slovic (1938–), from the 1980s, developed a two-dimensional model of human risk perception. The two axes: dread (the feeling of fear) and unknown.

"Subjective evaluation of risk is decided not only by objective probability and impact but varies greatly along the two axes of 'how dreadful it feels (dread)' and 'how unknown (unknown).' Between nuclear accidents and automobile accidents, both probability and fatality rate differ greatly, but people's evaluations line up differently from the objective data." — paraphrase of Paul Slovic, "Perception of Risk," Science (1987)

Slovic's finding has become the foundation of risk communication. When, in pharmaceutical material review, one imagines "if this were reported as a major pharmaceutical incident," that imagination amplifies dread and operates in the direction of overrating risk. As a safety-side bias it functions in itself, but when it operates excessively it generates the chain of over-finding and "just in case." The discipline of observing how strongly dread is operating within oneself supports the quality of risk judgement.

04Beck, "Risk Society" — Risk Is Not Individual Event but Social Structure

The German sociologist Ulrich Beck (1944–2015), in Risikogesellschaft (1986), diagnosed late-twentieth-century society as a risk society.

"The central problem of modern society has shifted from the distribution of wealth to the distribution of risk. Risk is not an individual event but is woven into the very structure of society. Therefore, the response to risk is not completed by the individual's judgement alone; it requires the design of social mechanisms." — paraphrase of Ulrich Beck, Risk Society (1986)

Applied to pharmaceuticals, Beck's implication is this: even by stuffing risk excessively into individual materials, the risk of society as a whole does not fall. Rather, by situating risk within the social mechanisms — the organisation's processing capacity, the industry's trust, the evolution of regulation, the communication of information to patients — the overall risk falls as a result.

This is not to say that individual findings may be sloppy. It demands the dual-layer perspective of being simultaneously conscious of the quality of individual findings and the design of social mechanisms.

05Aristotle's "Mean" — The Place of Virtue, Neither Excess nor Deficiency

The ancient Greek Aristotle, in Nicomachean Ethics, defined virtue as the mean (mesotēs).

"Virtue is the mean between excess and deficiency. Courage is the mean between recklessness and cowardice; temperance is the mean between licence and insensibility; liberality is the mean between profligacy and parsimony." — paraphrase of Aristotle, Nicomachean Ethics, Book II

Let us apply Aristotle's concept of the mean to risk judgement. The ideal response to risk is neither underestimation nor overestimation but the mean in that context. The continuing increase of "just in case" findings is excess (the bias of inhibition). To make light of important risks is deficiency (the bias of optimism). The mean is the judgement that discerns the "appropriate position" that differs by context.

In the pharmaceutical field, placing findings on every material with the same weight is not the mean. Changing the quantity and depth of findings according to context (the risk hierarchy of the product, the vulnerability of the patient population, the reach of the medium, the possibility of misunderstanding). This is the applied form of what Aristotle called phronesis (practical wisdom).

06The Buddha's "Middle Way" — The Eastern Response of Avoiding Both Extremes

From the Eastern lineage, the classical proposition most deeply applicable to risk judgement. The Middle Way (madhyamā pratipad), said to be taught by the Buddha (5th–6th c. BCE) in the first turning of the Dharma wheel after awakening.

Monks, the renunciant should avoid two extremes. One is to abandon oneself to the objects of desire. The other is to give oneself over to mortification. The Tathāgata has awakened to the Middle Way, which avoids both extremes.
— gist from the Dhammacakkappavattana Sutta (the Setting in Motion of the Wheel of the Dharma)

The Buddha's Middle Way, from a lineage different from Aristotle's mean, points to a strikingly similar place. The two extremes are often the same trap in disguise. The extreme of aiming for zero risk and the extreme of making light of risk — both are distortions of cognition. The Middle Way is not the midpoint between the two extremes but the very perspective from which both extremes can be surveyed.

In the field of regulatory review, when one hesitates whether to issue a correction, apply the Buddha's question. "Is the self that would issue this finding being pulled by the extreme of zero risk? Is the self that would not issue it being pulled by the extreme of making light?" The moment one becomes conscious of the two extremes, the position of the Middle Way comes into view.

07Taleb, "Fragile and Antifragile" — The Hidden Cost of Pursuing Zero Risk

The Lebanese-American probability researcher Nassim Nicholas Taleb (1960–), in Antifragile (2012), distinguished three responses to risk.

Fragile

Dislikes variation, breaks

A system that excessively defends, aiming for zero risk. At a glance safe, but if even one unforeseen event occurs, it breaks badly.

Robust

Absorbs variation

Accepts a degree of risk and endures without breaking. Does not improve, but does not break.

Antifragile

Grows stronger from variation

Learns from moderate risk and small failures, and the system grows stronger. The immune system, evolution, market competition are representative examples.

"The system that aims at zero risk often becomes the most fragile. It has no room to absorb variation, and a small shock generates a chain reaction. A healthy system becomes antifragile by experiencing moderate variation." — paraphrase of Nassim Taleb, Antifragile (2012)

Taleb's implication applies to pharmaceutical organisations as well. The organisation that continues over-finding in pursuit of zero risk becomes, ironically, the most fragile. The chain of findings expands the rules, the field's capacity for judgement thins, and the capacity to respond to truly important risks drops. Conversely, the organisation that accepts moderate risk and learns from small failures grows antifragile and stronger over the long term. The pursuit of zero risk itself generates great risk — Taleb formalised this paradox in the language of probability.

08The Hidden Costs of Over-Finding

Let us bring the abstract down to the hidden costs in the field. Over-finding is often justified as "for safety," but it actually generates several costs.

Cost 1

The burial of important findings

Of ten findings, the two truly important ones become buried among the remaining eight "just in case" items. The receiver tries to treat all equally and loses the difference in importance.

Cost 2

The receiver's defence and the deterioration of relationship

When the cognition "this reviewer always finds something" fixes, the receiver begins to react to form rather than content. The quality of the next dialogue drops.

Cost 3

The pressure on processing capacity

Over-finding is a burden of time and cognition for both the issuer and the receiver. The organisation's overall processing capacity cannot be directed to the truly important cases.

Cost 4

The atrophy of judgement

When a culture of competing by number rather than quality of findings fixes, the organisation's very capacity for judgement atrophies. The typical image of Taleb's "fragile" organisation.

These costs often accumulate while invisible. Over-finding is not an investment in safety but an investment in another risk — this perspective is the core of the volume.

09An Adult Relationship with Risk in the Pharmaceutical Field

Let us bring it down to the field. How to apply the wisdom of this volume in the scene where a reviewer hesitates whether to issue one finding.

CASE 1

The "just in case" finding

Without this finding, what concrete adverse effect would there be? If no concrete example comes to mind, it is "just in case" — a candidate for over-finding.

CASE 2

The finding pulled by dread

Is the imagination "if this became a major problem" pulling the judgement? Dread is a safety-side bias, but when it operates excessively it passes beyond the mean.

CASE 3

Vigilance against the bias of making light

Do not forget the inspection in the opposite direction. The judgement "this is trivial" may be an optimism bias. The mean is also far from the side of making light, not only from the zero-risk side.

These are not practices for bringing risk to zero, but practices for handling risk maturely. What cannot be made zero is not to be forced toward zero but placed at the appropriate position. This is Aristotle's mean, the Buddha's Middle Way, and Taleb's antifragility.

10An Adult Relationship with Risk — Four Practices

To bring the same place to which the six traditions pointed down into daily practice, four practices are set here.

Practice 1

The question that exposes "just in case"

Can you say one concrete adverse effect if this finding were not issued? If not, it is "just in case." Think one step further about whether to issue.

Practice 2

Be conscious of both extremes (Middle Way)

The Buddha's question — "the extreme of pursuing zero risk" and "the extreme of making light" — which am I pulled by now? The moment of awareness of both extremes, the position of the Middle Way comes into view.

Practice 3

Observe the degree of dread (Slovic)

Is the imagination "if this became a major problem" pulling the judgement? Dread cannot be erased but can be observed.

Practice 4

Look squarely at the hidden costs of over-finding (Taleb)

Over-finding is not investment in safety but investment in another risk. The burial of important findings, the deterioration of relationships, the pressure on processing capacity, the atrophy of judgement — these lurk behind.

In Closing

Zero risk does not exist. This is not an expression of weakness but a fact on which probability and cognitive science agree. Sunstein, Slovic, Beck, Aristotle, the Buddha, Taleb — six traditions pointed, in different words, to the same place. An adult relationship with risk is not bringing risk to zero but placing it at the appropriate position. Aristotle's mean, the Buddha's Middle Way, and Taleb's antifragility illuminate the same place from different angles.

"Let me note this just in case" — when you are about to write this, ask again. "Can I say one concrete adverse effect if this were not noted?" If yes, issue. If no, think one step further. That is the entry to an adult relationship with risk.

Key Points — Three to Take Away
  1. Zero risk is impossible in principle. The more "just in case" findings accumulate, the more another risk grows (the burial of important findings, the deterioration of relationships, the pressure on processing capacity, the atrophy of judgement).
  2. Aristotle's mean, the Buddha's Middle Way, Taleb's antifragility — three traditions point to the same place. The very perspective from which both extremes (zero-risk pursuit and making light) can be surveyed is the Middle Way.
  3. Over-finding is not investment in safety but investment in another risk. The discipline of asking "can I say one concrete adverse effect if this finding were not issued?" before issuing supports the quality of judgement.
References
  1. Sunstein, Cass R. Laws of Fear: Beyond the Precautionary Principle. Cambridge: Cambridge UP, 2005.
  2. Slovic, Paul. "Perception of Risk." Science 236 (4799), 1987, pp. 280–285.
  3. Beck, Ulrich. Risikogesellschaft: Auf dem Weg in eine andere Moderne. Frankfurt am Main: Suhrkamp, 1986. (English: Risk Society: Towards a New Modernity, trans. Mark Ritter, London: Sage, 1992)
  4. Aristotle, Nicomachean Ethics, Book II. On the mean (Ancient Greece, late 4th c. BCE).
  5. Dhammacakkappavattana Sutta (Setting in Motion of the Wheel of the Dharma), Samyutta Nikāya 56.11. (Pāli Canon)
  6. Taleb, Nassim Nicholas. Antifragile: Things That Gain from Disorder. New York: Random House, 2012.